These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38837865)

  • 1. RETRACTION: Hsp90-binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity.
    Mol Oncol; 2024 Aug; 18(8):2060. PubMed ID: 38837865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retraction: p53 loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.
    Mol Oncol; 2024 Mar; 18(3):778. PubMed ID: 38439146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.
    Mol Oncol; 2024 Aug; 18(8):2061. PubMed ID: 38837853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTION: Microrna-379 Suppresses Osteosarcoma Progression by Targeting PDK1.
    J Cell Mol Med; 2024 Aug; 28(15):e18567. PubMed ID: 39113402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction Statement: Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
    Mol Oncol; 2023 Jul; 17(7):1454. PubMed ID: 37231586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETRACTION: The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
    Mol Oncol; 2024 Oct; 18(10):2602. PubMed ID: 38949165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21
    FEBS Lett; 2024 Jun; 598(11):1449. PubMed ID: 38747074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction statement: Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition.
    Mol Oncol; 2023 Aug; 17(8):1692. PubMed ID: 37471281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RETRACTION: Crestal bone loss evaluation in osseotite expanded platform implants: a 5-year study.
    Clin Oral Implants Res; 2024 Jun; 35(6):683. PubMed ID: 38773548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retraction Statement: Circ-TCF4.85 silencing inhibits cancer progression through microRNA-486-5p-targeted inhibition of ABCF2 in hepatocellular carcinoma.
    Mol Oncol; 2023 Jul; 17(7):1453. PubMed ID: 37231579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    J Cell Mol Med; 2024 Apr; 28(8):e18314. PubMed ID: 38655709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential.
    FEBS Lett; 2024 Oct; 598(20):2615. PubMed ID: 39334560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RETRACTION: α-Synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway.
    FASEB J; 2024 Aug; 38(16):e70007. PubMed ID: 39177105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.
    J Cell Mol Med; 2024 Mar; 28(6):e18199. PubMed ID: 38439141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Mol Oncol; 2024 Aug; 18(8):2062. PubMed ID: 38873938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RETRACTION: Extensive degradation of myelin basic protein isoforms by calpain following traumatic brain injury.
    J Neurochem; 2025 Jan; 169(1):e16229. PubMed ID: 39302081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETRACTION: Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
    Cancer Med; 2024 Oct; 13(19):e70301. PubMed ID: 39387478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RETRACTION.
    J Cell Physiol; 2024 Oct; 239(10):e31409. PubMed ID: 39221865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retraction: CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells.
    J Cell Mol Med; 2024 Mar; 28(6):e18078. PubMed ID: 38073225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3.
    J Cell Mol Med; 2024 Aug; 28(15):e18566. PubMed ID: 39109524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.